North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

Press releases published on November 9, 2026

3 hours ago

Immunocore to present at upcoming investor conferences

Indeterminate GlobeNewswire

3 hours ago

Silexion Therapeutics Announces 1-for-24 Reverse Share Split

Indeterminate GlobeNewswire

3 hours ago

TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026

Indeterminate GlobeNewswire

3 hours ago

GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

3 hours ago

NovaBridge Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

3 hours ago

Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire

3 hours ago

J-Star Holding Co., Ltd. Highlights U.S. Operational Progress with Delegation Visit from Global Tier 1 Carbon Fiber Manufacturer

Indeterminate GlobeNewswire

3 hours ago

Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026

Indeterminate GlobeNewswire

3 hours ago

Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

3 hours ago

Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia

Indeterminate GlobeNewswire

3 hours ago

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout

Indeterminate GlobeNewswire

3 hours ago

Editas Medicine Announces Third Quarter 2026 Results and Business Updates

Indeterminate GlobeNewswire

3 hours ago

Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence

Indeterminate GlobeNewswire

3 hours ago

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire

3 hours ago

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

3 hours ago

Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

3 hours ago

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

Indeterminate GlobeNewswire